NCT00016731

Brief Summary

The purpose of this study is to use brain imaging technology to compare how the brains of adolescents and adults are activated during tasks that involve emotional responses. Evidence suggests that adolescents and adults experience activation in similar brain regions when they engage in tasks that involve the processing of emotional stimuli. However, the degree of task-associated activation may differ between adolescents and adults. This study will use functional magnetic resonance imaging (fMRI) to compare brain activation patterns in adolescents and adults. This study will also be used to develop emotion-evoking fMRI tasks to determine whether there are puberty and age-linked components of brain development.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2001

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 29, 2001

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

May 31, 2001

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 1, 2001

Completed
16.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 18, 2017

Completed
Last Updated

December 17, 2019

Status Verified

October 18, 2017

First QC Date

May 31, 2001

Last Update Submit

December 14, 2019

Conditions

Keywords

DepressionAnxietyCAHAdultsFMPPEmotionCushing's SyndromeAdolescenceMagnetic Resonance ImagingfMRIHealthy VolunteerHVMRI

Eligibility Criteria

Age8 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age: 9-25 (adolescents/young adults); 25-35 (adults).
  • Consent: can give consent/assent. Parents will provide consent for all minors.
  • IQ: all subjects will have an IQ greater than 70; assessment relies on WASI.
  • Psychopathology: all subjects will be free of any current psychiatric disorder as well as lifetime history of psychosis, pervasive developmental disorder, major affective disorder, panic disorder, obsessive compulsive disorder, conduct disorder, ADHD, and anorexia. Assessment relies on comprehensive psychiatric interview.
  • Age: 9-25 (adolescents/young adults); 25-35 (adults).
  • Consent: can give consent/assent. Parents will provide consent for all minors.
  • IQ: all subjects will have an IQ greater than 70. Assessment relies on WASI

You may not qualify if:

  • Any medical condition that increases risk for MRI (e.g. pacemaker, metallic foreign body in eye)
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, Maryland, 20892, United States

Location

Related Publications (3)

  • Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lepine JP, Newman SC, Oakley-Browne MA, Rubio-Stipec M, Wells JE, Wickramaratne PJ, Wittchen HU, Yeh EK. The cross-national epidemiology of panic disorder. Arch Gen Psychiatry. 1997 Apr;54(4):305-9. doi: 10.1001/archpsyc.1997.01830160021003.

    PMID: 9107146BACKGROUND
  • Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994 Jan;51(1):8-19. doi: 10.1001/archpsyc.1994.03950010008002.

    PMID: 8279933BACKGROUND
  • Pine DS, Cohen P, Gurley D, Brook J, Ma Y. The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Arch Gen Psychiatry. 1998 Jan;55(1):56-64. doi: 10.1001/archpsyc.55.1.56.

    PMID: 9435761BACKGROUND

MeSH Terms

Conditions

Mood DisordersNeurobehavioral ManifestationsDepressionAnxiety DisordersCushing Syndrome

Condition Hierarchy (Ancestors)

Mental DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehaviorAdrenocortical HyperfunctionAdrenal Gland DiseasesEndocrine System Diseases

Study Officials

  • Monique Ernst, M.D.

    National Institute of Mental Health (NIMH)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2001

First Posted

June 1, 2001

Study Start

May 29, 2001

Study Completion

October 18, 2017

Last Updated

December 17, 2019

Record last verified: 2017-10-18

Locations